Supernus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Supernus Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Supernus Pharmaceuticals Inc
Rating: 2.053999875
Author: Trendlyne DVM scores

Momentum Trap

about

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse ...

49.47 -0.23 (-0.46%)

69.65% Gain from 52W Low

374.9K

XNAS Volume

XNAS 02 Jan, 2026 4:30 PM (EST)

Low Financial Strength

33.3 / 100

Expensive Valuation

28.3 / 100

Technically Moderately Bullish

69.3 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 24%

6 analysts

Supernus Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Supernus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse ...

69.65% Gain from 52W Low

SWOT Analysis

Supernus Pharma Inc Live Price Chart